Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Angina IV: Management01:26

Angina IV: Management

215
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
215
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

236
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
236

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Unified Explanation for Drug Repurposing and Pharmacological Pleiotropy Based on Classical and Statistical Thermodynamics.

Pharmacology research & perspectives·2025
Same author

Approaches to repurposing reverse transcriptase antivirals in cancer.

British journal of clinical pharmacology·2025
Same author

Melatonin: A Review of the Evidence for Use in Hospital Settings.

Pharmacology research & perspectives·2025
Same author

Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"?

Pharmacology research & perspectives·2024
Same author

Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma.

Cells·2024
Same author

Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitors.

Pharmacology research & perspectives·2024
Same journal

Alterations in Abdominal Blood Flows After Drinking Coffee.

Pharmacology research & perspectives·2026
Same journal

Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees.

Pharmacology research & perspectives·2026
Same journal

Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum.

Pharmacology research & perspectives·2026
Same journal

Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim-Sulfamethoxazole Acute Respiratory Distress Syndrome.

Pharmacology research & perspectives·2026
Same journal

Differential Impact of Pharmacokinetic and Pharmacodynamic Variability on Response to Combination Therapy.

Pharmacology research & perspectives·2026
Same journal

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects.

Pharmacology research & perspectives·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

Rethinking Statin Dosage in Coronary Disease.

Simon B Dimmitt1,2, Hans G Stampfer3, Michael C Kennedy4

  • 1Division of Internal Medicine, Medical School, University of Western Australia, Crawley, Australia.

Pharmacology Research & Perspectives
|December 16, 2025
PubMed
Summary
This summary is machine-generated.

Statins are the only cholesterol drugs proven to improve survival, but mid-range doses offer maximum benefits for cardiovascular disease patients with fewer risks. Higher doses show minimal mortality reduction.

Keywords:
adverse eventsatheromacholesterolcoronary diseaseeffective dose 50 (ED50)statin

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.7K

Related Experiment Videos

Last Updated: Jan 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.7K

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease management relies on risk factor control and revascularization.
  • Despite evidence, statin uptake remains low globally (<3%) and in developed nations (~10%).
  • Statins are the sole cholesterol-lowering drugs proven to reduce mortality, primarily in symptomatic coronary patients at mid-range doses.

Purpose of the Study:

  • To evaluate the efficacy and safety of different statin dosages for cardiovascular disease.
  • To determine optimal cholesterol targets for maximizing survival.
  • To compare statin efficacy against newer lipid-lowering agents.

Main Methods:

  • Review of population studies on cholesterol levels and mortality.
  • Analysis of six large randomized controlled trials (RCTs) comparing high-dose versus mid-range statin doses.
  • Examination of data on newer drugs like PCSK9 inhibitors and ezetimibe.

Main Results:

  • Population studies indicate lower coronary events and mortality with lower cholesterol, but total mortality rises below 5 mmol/L.
  • RCTs showed marginal reductions in coronary events with higher statin doses, but no significant mortality decrease.
  • Newer lipid-lowering drugs have not demonstrated improved mortality benefits.

Conclusions:

  • Mid-range statin doses achieve maximal improvements in total mortality for cardiovascular disease patients.
  • Higher statin doses increase toxicity without substantial mortality benefits.
  • Optimal management includes sufficient statin dosage, weight reduction, and other pharmacotherapies.